Literature DB >> 1295754

Resistance of anaerobic bacteria to antimicrobial agents in Spain.

F Baquero1, M Reig.   

Abstract

As a consequence of antibiotic consumption, the entire microbial ecosystem attached to man is evolving towards resistance. In Spain, penicillin resistance (MIC > 0.5 mg/l) is found in about 10% of Peptostreptococcus, Clostridium perfringens and Eubacterium, and in 50% of Veillonella. Cefoxitin resistance ( > 2 mg/l) is present in 10 to 20% of Peptostreptococcus and Clostridium, and in 50% of Eubacterium; 21% of Bacteroides (fragilis group) strains are resistant to 16 mg/l. A very low rate of imipenem resistance (> or = 128 mg/l) is found among Bacteroides (1%), but for 5% of the isolates MICs of imipenem are 2 to 4 mg/l. Metronidazole resistance ( > 8 mg/l) is found in 5 to 10% of Peptostreptococcus, Clostridium and Veillonella, and in less than 1% of the Bacteroides fragilis group. Erythromycin resistance ( > 2 mg/l) is present in over two-thirds of the Peptostreptococcus, Veillonella and Fusobacterium isolates, and in 27% of the Clostridium perfringens strains. Clindamycin resistance ( > 4 mg/l) is found in 10 to 20% of the Peptostreptococcus, Clostridium and Eubacterium isolates, and in 20% of the Bacteroides of the fragilis group, this rate being higher (30%) among faecal isolates.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1295754     DOI: 10.1007/bf01967792

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  5 in total

1.  Resistance of anaerobic bacteria to antimicrobial agents.

Authors:  M T Peláez; E Cercenado; M Rodríguez-Créixems; E Bouza
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

2.  Resistance of Peptostreptococcus spp. to macrolides and lincosamides: inducible and constitutive phenotypes.

Authors:  M Reig; A Moreno; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  1992-03       Impact factor: 5.191

3.  Transferable plasmid-linked chloramphenicol acetyltransferase conferring high-level resistance in Bacteroides uniformis.

Authors:  J V Martínez-Suárez; F Baquero; M Reig; J C Pérez-Díaz
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

4.  Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents.

Authors:  C Betriu; E Campos; C Cabronero; C Rodriguez-Avial; J J Picazo
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

5.  Evolution of antimicrobial susceptibility in isolates of the Bacteroides fragilis group in Spain.

Authors:  J E García-Rodríguez; J E García-Sánchez
Journal:  Rev Infect Dis       Date:  1990 Jan-Feb
  5 in total
  3 in total

Review 1.  Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infections.

Authors:  J A Balfour; H M Bryson; R N Brogden
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

2.  Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinem, and quinupristin-dalfopristin) against Bacteroides fragilis group: comparison with the activities of 14 other agents.

Authors:  C Betriu; M Gómez; M L Palau; A Sánchez; J J Picazo
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

Review 3.  Human infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre's syndrome.

Authors:  Terry Riordan
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.